Pregnancy and congenital complete atrioventricular block: management during pregnancy and periparturient period (RCD code: VII-V)


Full Text:

PDF

Abstract


Complete atrioventricular block (AVB) is rare during pregnancy. Congenital atrioventricular block is the most common type of heart
block in this group of patients. About one‑third of female patients with complete AVB remain asymptomatic until adulthood and may be first diagnosed during pregnancy. We present a case of a 31‑year‑old pregnant woman with complete AVB who was in her final stage of pregnancy. After reviewing the various advantages and disadvantages of feasible approaches with the patient, we decided to use fluoroscopy‑guided temporary backup pacemaker implantation. Estimated radiation skin dose was small and safe. The patient agreed to this treatment plan. Four days prior to scheduled cesarean delivery (39 weeks of gestation), during a one‑day stay in the hospital, the patient
underwent single‑chamber temporary pacemaker implantation (using transvenous active fixation lead and external re‑sterilized pacemaker). The abdominal and pelvic regions were covered with a lead shield. The caesarean delivery was uneventful and the baby was healthy with an Apgar score of 10. JRCD 2017; 3 (6): 205–209.

Keywords


pregnancy; complete atrioventricular block; pacemaker; active fixation lead; rare disease

References


Kivrak T, Kivrak V, Kivrak YY, et al. Presenting of pregnant woman with atrioventricular block. SM J Case Rep. 2017; 3(5): 1058.

Regitz-Zagrosek V, Blomstrom-Lundqvist C, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 3147–3197.

Wiśniowska-Śmiałek S, Leśniak-Sobelga A, Kostkiewicz M, et al. Arrhythmias in pregnancy (RCD code: VII-V). J Rare Cardiovasc Dis 2016; 2 (6): 177–180.

Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 2009; 6: 1085–1104.

Malecka B, Zabek A. Infectious complications of electrotherapy: theory and practice. Pol Arch Med Wewn 2016; 126: 440–442.

Hidaka N, Chiba Y, Fukushima K, et al. Pregnant women with complete atrioventricular block: perinatal risks and review of management. Pacing Clin Electrophysiol 2 011; 3 4 : 1161–1176 .

Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014; 35: 2383–2431.

Zei PC, Eckart RE, Epstein LM. Modified temporary cardiac pacing using transvenous active fixation leads and external re-sterilized pulse generators. J Am Coll Cardiol 2006; 47: 1487–1489.

Payne J, Lo M, Paydak H, et al. Near-zero fluoroscopy implantation of dual-chamber pacemaker in pregnancy using electroanatomic mapping. HeartRhythm Case Rep 2017; 3: 205–209.

Karbarz D, Stec PJ, Deutsch K, et al. Zero-fluoroscopy catheter ablation of symptomatic pre-excitation from non-coronary cusp during pregnancy. Kardiol Pol 2017; 75: 1351.

Aldrighetti L, Paganelli M, Arru M, et al. Complications of blind placement technique in 980 subcutaneous infusion ports. J Vasc Access 2000; 1: 28–32.

Chihrin SM, Mohammed U, Yee R, et al. Utility and cost effectiveness of temporary pacing using active fixation leads and an externally placed reusable permanent pacemaker. Am J Cardiol 2006; 98: 1613–1615.

Bordachar P, Zachary W, Ploux S, et al. Pathophysiology, clinical course, and management of congenital complete atrioventricular block. Heart Rhythm 2013; 10: 760–766.

Kojic EM, Hardarson T, Sigfusson N, et al. The prevalence and prognosis of third-degree atrioventricular conduction block: the Reykjavik study. J Intern Med 1999; 246: 81–86.

Writing Group M, Mozaffarian D, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 2016; 133: e38-360.

Monsieurs KG, Nolan JP, Bossaert LL, et al. European Resuscitation Council Guidelines for Resuscitation 2015: Section 1. Executive summary. Resuscitation 2015; 95: 1–80.

Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013; 34: 2281–2




DOI: http://dx.doi.org/10.20418%2Fjrcd.vol3no6.313

Refbacks

  • There are currently no refbacks.
Journal of Rare Cardiovascular Diseases (JRCD)
John Paul II Hospital in Kraków, 80 Prądnicka Str., 31-202 Kraków, Poland
Phone: +48 (12) 614 33 99, +48 (12) 614 34 88 Fax: +48 (12) 614 34 88
e-mail: rarediseases@szpitaljp2.krakow.pl
Published by SoftQ sp. z o.o.
ul. Oleandry 2, 30-063 Kraków, Poland
Phone: +48 (12) 444 1650 Fax: +48 (12) 444 1659
e-mail: softq@softq.pl